Explore ›
Finding
Finding
decline
In patients with NAFLD and diabetes, use of insulin in combination with oral diabetes medications was associated with a 1.5 to 1.7-fold higher risk of hepatocellular carcinoma compared with no medication.
| Effect size | HR 1.53 |
| CI | 95% CI 1.26-1.86 |
| Comparator | no diabetes medication |
| Effect summary | decline; HR 1.53; CI: 95% CI 1.26-1.86 |
Connected entities
Interventions
Conditions
Outcomes
Populations
Source
PMC9107529
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease